Columbia Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-304	Closed	-$320K	–	288
2024 Q3	$320K	Hold	304	–	–	0.06%	153
2024 Q2	$320K	Buy	304 +9	+3%	+$8.72K	0.06%	147
2024 Q1	$259K	Hold	295	–	–	0.05%	150
2023 Q4	$259K	Sell	295 -30	-9%	-$24.7K	0.05%	150
2023 Q3	$267K	Sell	325 -40	-11%	-$31.4K	0.06%	144
2023 Q2	$262K	Sell	365 -55	-13%	-$42.4K	0.06%	150
2023 Q1	$345K	Sell	420 -250	-37%	-$189K	0.08%	128
2022 Q4	$483K	Hold	670	–	–	0.12%	113
2022 Q3	$462K	Sell	670 -20	-3%	-$12.6K	0.12%	112
2022 Q2	$408K	Buy	+690	New	+$449K	0.1%	117
2021 Q4	$916K	Sell	1,450 -100	-6%	-$61.5K	0.19%	85
2021 Q3	$938K	Buy	1,550 +466	+43%	+$289K	0.2%	84
2021 Q2	$605K	Buy	+1,084	New	+$549K	0.13%	108
2019 Q2	–	Sell	-795	Closed	-$326K	–	203
2019 Q1	$326K	Buy	795 +310	+64%	+$128K	0.09%	140
2018 Q4	$181K	Hold	485	–	–	0.06%	163
2018 Q3	$196K	Buy	+485	New	+$185K	0.05%	174